Algert Global LLC Boosts Holdings in Aspen Aerogels, Inc. (NYSE:ASPN)

Algert Global LLC grew its position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 60.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 127,764 shares of the construction company’s stock after purchasing an additional 48,007 shares during the period. Algert Global LLC owned approximately 0.17% of Aspen Aerogels worth $3,538,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Point72 Hong Kong Ltd purchased a new position in Aspen Aerogels during the second quarter worth about $84,000. nVerses Capital LLC purchased a new position in shares of Aspen Aerogels during the second quarter worth about $95,000. Quent Capital LLC bought a new position in shares of Aspen Aerogels in the third quarter worth approximately $118,000. Point72 DIFC Ltd bought a new stake in Aspen Aerogels during the second quarter valued at approximately $121,000. Finally, Public Employees Retirement Association of Colorado purchased a new position in Aspen Aerogels in the 2nd quarter worth approximately $145,000. Institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently weighed in on ASPN shares. Barclays dropped their target price on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Tuesday, November 12th. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a report on Wednesday, November 13th. HC Wainwright reissued a “buy” rating and issued a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Roth Mkm reduced their price objective on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. Finally, TD Cowen increased their target price on Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. One equities research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $28.70.

Insider Activity

In related news, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at $14,523,709.20. The trade was a 11.58 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 4.30% of the company’s stock.

Aspen Aerogels Price Performance

NYSE ASPN opened at $15.05 on Tuesday. Aspen Aerogels, Inc. has a one year low of $10.31 and a one year high of $33.15. The stock has a 50-day moving average of $20.88 and a 200 day moving average of $24.23. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The company has a market capitalization of $1.23 billion, a price-to-earnings ratio of 1,506.01 and a beta of 2.21.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.